Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials: A Systematic Review and Meta-Analysis

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?

Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · see citing works

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement

Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826 · see citing works

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442 · see citing works

Selective publication of antidepressant trials and its influence on apparent efficacy

Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435 · see citing works

Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial

(2004) · JAMA · doi:10.1001/jama.292.7.807 · Cited by 1,735 · see citing works

Experimenter Effects in Behavioral Research

McGuigan, F. J., & Rosenthal, R. (1968) · The American Journal of Psychology · doi:10.2307/1420816 · Cited by 1,633 · see citing works

Sertraline treatment of major depression in patients with acute MI or unstable angina

Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414 · see citing works

Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing

Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109 · see citing works

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study (POTS) Randomized Controlled Trial

(2004) · JAMA · doi:10.1001/jama.292.16.1969 · Cited by 1,107 · see citing works

Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive–compulsive disorder

Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048 · see citing works

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1× · see citing works

Nonspecific medication side effects and the nocebo phenomenon

Barsky, A. J. (2002) · JAMA · doi:10.1001/jama.287.5.622 · Cited by 784 · see citing works

Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder

Brady, K. T., Pearlstein, T. B., Asnis, G. M., Baker, D. G., ROTHBAUM, B. O., Sikes, C. R., & Farfel, G. M. (2000) · JAMA · doi:10.1001/jama.283.14.1837 · Cited by 696 · see citing works

Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial

Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., et al. (2007) · JAMA · doi:10.1001/jama.297.4.367 · Cited by 658 · see citing works

When words are painful: unraveling the mechanisms of the nocebo effect

Benedetti, F., Lanotte, M., Lopiano, L., & Colloca, L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.020 · Cited by 636 · see citing works

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441703 · Cited by 588 · see citing works

Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection

Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., Longis, P. D., Caputo, S. L., Narciso, P., Pauluzzi, S., Carosi, G., et al. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200112150-00006 · Cited by 473 · see citing works

Multicenter, Double-blind Comparison of Sertraline and Placebo in the Treatment of Posttraumatic Stress Disorder

Davidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.485 · Cited by 470 · see citing works

Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder

March, J. S., Biederman, J., Wolkow, R., Safferman, A. Z., Mardekian, J., Cook, E. H., Cutler, N. R., Dominguez, R., Ferguson, J. M., Müller, B., et al. (1998) · JAMA · doi:10.1001/jama.280.20.1752 · Cited by 460 · see citing works

How prior experience shapes placebo analgesia

Colloca, L., & Benedetti, F. (2006) · Pain · doi:10.1016/j.pain.2006.04.005 · Cited by 443 · see citing works

The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect

Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2947-06.2006 · Cited by 419 · see citing works

Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia

Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415 · see citing works

Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive Disorder Two Randomized Controlled Trials

Wagner, K. D. (2003) · JAMA · doi:10.1001/jama.290.8.1033 · Cited by 413 · see citing works

The role of learning in nocebo and placebo effects

Colloca, L., Sigaudo, M., & Benedetti, F. (2008) · Pain · doi:10.1016/j.pain.2008.02.006 · Cited by 411 · see citing works

Fluvoxamine for Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Controlled, Multicenter Trial

Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H.-M., Claghorn, J. L., Gaffney, G., Greist, J. H., Holland, D., McConville, B. J., Pigott, T. A., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00017 · Cited by 398 · see citing works

Treating Depression in Alzheimer Disease: Efficacy and Safety of Sertraline Therapy, and the Benefits of Depression Reduction: The DIADS

Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398 · see citing works

Clomipramine in the Treatment of Patients With Obsessive-Compulsive Disorder

(1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320054008 · Cited by 386 · see citing works

Fluoxetine for the Treatment of Childhood Anxiety Disorders

Birmaher, B. B., Axelson, D., Monk, K., Kalas, C., Clark, D. B., Ehmann, M., Bridge, J. A., Heo, J., & Brent, D. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000037049.04952.9f · Cited by 380 · see citing works

The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients

Vase, L., Robinson, M. E., Verne, N. G., & Price, D. D. (2003) · Pain · doi:10.1016/s0304-3959(03)00073-3 · Cited by 373 · see citing works

Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy

Burnier, M. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.04.006 · Cited by 356 · see citing works

Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients

Burke, W. J., Gergel, I. P., & Bose, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0410 · Cited by 352 · see citing works

Treatment of Posttraumatic Stress Disorder With Amitriptyline and Placebo

Davidson, J. R. T. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150059010 · Cited by 349 · see citing works

Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder)

Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W., & Gergel, I. P. (1998) · JAMA · doi:10.1001/jama.280.8.708 · Cited by 348 · see citing works

Fluoxetine in post-traumatic stress disorder

Davidson, J. R. T., Roth, S., & Newman, E. (1991) · Journal of Traumatic Stress · doi:10.1007/bf00974559 · Cited by 347 · see citing works

Clomipramine Hydrochloride in Childhood and Adolescent Obsessive-Compulsive Disorder—a Multicenter Trial

DeVeaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D. P., FONTAINE, R., Greist, J. H., Reichler, R. J., Katz, R. J., & Landau, P. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00008 · Cited by 345 · see citing works

Somatization Symptoms and Hypochondriacal Features in the General Population

Rief, W., Hessel, A., & Braehler, E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00012 · Cited by 339 · see citing works

Double-Blind, Crossover Trial of Fluoxetine and Placebo in Children and Adolescents with Obsessive-Compulsive Disorder

Riddle, M. A., Scahill, L. D., King, R. A., Hardin, M. T., Anderson, G. M., Ort, S. I., SMITH, J., Leckman, J. F., & Cohen, D. J. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199211000-00011 · Cited by 339 · see citing works

Paroxetine in the Treatment of Chronic Posttraumatic Stress Disorder

Tucker, P. M., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K., & Pitts, C. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1105 · Cited by 324 · see citing works

Fluoxetine Treatment for Obsessive-Compulsive Disorder in Children and Adolescents: A Placebo-Controlled Clinical Trial

GELLER, D. A., HOOG, S. L., Heiligenstein, J. H., Ricardi, R. K., Tamura, R., KLUSZYNSKI, S., Jacobson, J. G., & FLUOXETINE PEDIATRIC OCD STUDY TEAM (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00011 · Cited by 317 · see citing works

Placebo-Controlled Trial of Sertraline in the Treatment of Children With Generalized Anxiety Disorder

Rynn, M. A., Siqueland, L., & Rickels, K. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2008 · Cited by 316 · see citing works

A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive Disorder

Tollefson, G. D. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070051010 · Cited by 314 · see citing works

Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients

Price, D. D., Craggs, J. G., Verne, G. N., Perlstein, W. M., & Robinson, M. E. (2006) · Pain · doi:10.1016/j.pain.2006.08.001 · Cited by 271 · see citing works

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

van Vliet, I. M., den Boer, J. A., & Westenberg, H. G. M. (1994) · Psychopharmacology · doi:10.1007/bf02244762 · Cited by 270 · see citing works

Fluvoxamine Treatment of Social Phobia (Social Anxiety Disorder): A Double-Blind, Placebo-Controlled Study

Stein, M. B., Fyer, A. J., Davidson, J. R. T., Pollack, M. H., & Wiita, B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.756 · Cited by 263 · see citing works

Somatization in the population: from mild bodily misperceptions to disabling symptoms

Hiller, W., Rief, W., & Brähler, E. (2006) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-006-0082-y · Cited by 261 · see citing works

Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study

Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.3.374 · Cited by 261 · see citing works

Fluoxetine in Early Poststroke Depression

Wiart, L., Petit, H., Joseph, P.-A., Mazaux, J., & Barat, M. (2000) · Stroke · doi:10.1161/01.str.31.8.1829 · Cited by 259 · see citing works

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard-Andersen, L., Jp, G.-S., Kristensen, M., Refsum, H. E., Øfsti, E., Eriksson, S., & Syversen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03242.x · Cited by 258 · see citing works

Efficacy and Safety of Fluoxetine in the Treatment of Patients With Major Depression After First Myocardial Infarction: Findings From a Double-Blind, Placebo-Controlled Trial

Strik, J. J. M. H., Honig, A., Lousberg, R. L., Lousberg, A., Cheriex, E. C., Tuynman-Qua, H. G., Kuijpers, P. M. J. C., Wellens, H. J. J., & van Praag, H. M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200011000-00007 · Cited by 255 · see citing works

Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

Lepola, U. M., Loft, H., & Reines, E. H. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000074988.54339.7c · Cited by 254 · see citing works

Paroxetine in social phobia/social anxiety disorder

Baldwin, D. S., Bobes, J., Stein, D. J., Scharwächter, I., & Ml, F. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.2.120 · Cited by 252 · see citing works

Fluoxetine versus other types of pharmacotherapy for depression

Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub3 · Cited by 251 · see citing works

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

Trindade, E. M., Menon, D., Topfer, L.-A., & Coloma, C. (1998) · Europe PMC (PubMed Central) · Cited by 250 · see citing works

Paroxetine in the Treatment of Generalized Anxiety Disorder

Pollack, M. H., Zaninelli, R., Goddard, A. W., McCafferty, J. P., Bellew, K. M., Burnham, D. B., & Iyengar, M. K. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0508 · Cited by 246 · see citing works

Clomipramine in obsessive-compulsive disorder

Katz, R. J., DeVeaugh-Geiss, J., & Landau, P. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90408-t · Cited by 245 · see citing works

Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive Disorder

Greist, J. H. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160039008 · Cited by 243 · see citing works

A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial ofParoxetine in Children and Adolescents With Social Anxiety Disorder

Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., Gee, M., Davy, K., & Machin, A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1153 · Cited by 240 · see citing works

Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide

Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997) · Pain · doi:10.1016/s0304-3959(97)03346-0 · Cited by 238 · see citing works

Escitalopram 10???mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

Wade, A. G., Lemming, O. M., & Hedegaard, K. B. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200205000-00001 · Cited by 232 · see citing works

Paroxetine Treatment in Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

GELLER, D. A., Wagner, K. D., Emslie, G. J., Murphy, T. K., CARPENTER, D. J., Wetherhold, E., Perera, P., Machin, A., & GARDINER, C. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000138356.29099.f1 · Cited by 230 · see citing works

Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response

Geers, A. L., Helfer, S. G., Kosbab, K., Weiland, P. E., & Landry, S. J. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.08.011 · Cited by 225 · see citing works

Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study

Ameringen, M. A. V., Lane, R. M., Walker, J. R., Bowen, R. C., Chokka, P. R., Goldner, E. M., Johnston, D. G., Lavallée, Y.-J., Nandy, S., Pecknold, J. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.275 · Cited by 221 · see citing works

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia

Blomhoff, S., Haug, T. T., Hellström, K., Holme, I., Humble, M. B., Madsbu, H.-P., & Wold, J. E. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.179.1.23 · Cited by 218 · see citing works

Double-Blind Placebo-Controlled Pilot Study of Sertraline in Military Veterans With Posttraumatic Stress Disorder

Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R. M., & Austin, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00013 · Cited by 218 · see citing works

Double-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder

Ballenger, J. C., Wheadon, D. E., Steiner, M., Bushnell, W., & Gergel, I. P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.36 · Cited by 217 · see citing works

Fluoxetine Versus Placebo in Posttraumatic Stress Disorder

Martényi, F., Brown, E. B., Zhang, H., Prakash, A., & Koke, S. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0305 · Cited by 215 · see citing works

A Double-Blind, Randomized, Placebo-Controlled Trial of Escitalopram in the Treatment of Pediatric Depression

Wagner, K. D., Jonas, J. M., Findling, R. L., Ventura, D., & Saikali, K. G. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000192250.38400.9e · Cited by 210 · see citing works

Imipramine Treatment of Children with Separation Anxiety Disorder

KLEIN, R. G., KOPLEWICZ, H. S., & KANNER, A. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00005 · Cited by 201 · see citing works

Cardiovascular Effects of Tricyclic Antidepressants in Depressed Patients with Chronic Heart Disease

Veith, R. C., Raskind, M. A., Caldwell, J. H., Barnes, R., Gumbrecht, G., & Ritchie, J. L. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204223061603 · Cited by 199 · see citing works

Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study

Rickels, K., Zaninelli, R., McCafferty, J. P., Bellew, K. M., Iyengar, M. K., & Sheehan, D. V. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.749 · Cited by 197 · see citing works

Drug-Related Information Generates Placebo and Nocebo Responses That Modify the Drug Response

Flaten, M. A., Simonsen, T., & Olsen, H. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199903000-00018 · Cited by 190 · see citing works

Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled Trial

Roose, S. P., Sackeïm, H. A., Krishnan, K., Pollock, B. G., Alexopoulos, G. S., Lavretsky, H., Katz, I. R., Hakkarainen, H., & Old-Old Depression Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2050 · Cited by 189 · see citing works

Fluoxetine in Children and Adolescents With OCD: A Placebo-Controlled Trial

Liebowitz, M. R., Turner, S. M., Piacentini, J. C., Beidel, D. C., Clarvit, S. R., Davies, S. O., Graae, F., Jaffer, M., Lin, S., Sallee, F. R., et al. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00014 · Cited by 186 · see citing works

Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo

Fabre, L. F., Abuzzahab, F. S., Amin, M., Claghorn, J. L., MENDELS, J., Petrie, W. M., Dubé, S., & Small, J. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00178-8 · Cited by 184 · see citing works

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

Montgomery, S., Kasper, S. F., Stein, D. J., Hedegaard, K. B., & Lemming, O. M. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200103000-00002 · Cited by 184 · see citing works

Escitalopram in the treatment of generalized anxiety disorder: Double‐blind, placebo controlled, flexible‐dose study

Davidson, J. R. T., Bose, A., Korotzer, A., & Zheng, H. (2004) · Depression and Anxiety · doi:10.1002/da.10146 · Cited by 183 · see citing works

Side-Effect Profile of Fluoxetine in Comparison with Other SSRIs, Tricyclic and Newer Antidepressants: A Meta-Analysis of Clinical Trial Data

Brambilla, P., Cipriani, A., Hotopf, M., & Barbui, C. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-837806 · Cited by 181 · see citing works

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease

Petracca, G., Tesón, A., Chemerinski, E., Leiguarda, R. C., & STARKSTEIN, S. E. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.3.270 · Cited by 176 · see citing works

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder

Montgomery, S. A. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90266-o · Cited by 172 · see citing works

Multicenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression

Feighner, J. P., & Overø, K. F. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1204 · Cited by 169 · see citing works

Medication-Attributed Adverse Effects in Placebo Groups: Implications for Assessment of Adverse Effects

Rief, W., Avorn, J., & Barsky, A. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.2.155 · Cited by 167 · see citing works

An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major Depression

Schneider, L. S. S., Nelson, J. C., Clary, C. M., NEWHOUSE, P. A., Krishnan, K., Shiovitz, T. M., Weihs, K. L., & the Sertraline Elderly Depression Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1277 · Cited by 166 · see citing works

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory

Jenike, M. A., Hyman, S. E., Baer, L., Holland, A. J., Minichiello, W. E., Buttolph, L., D, P. S. M., Seymour, R., & Ricciardi, J. N. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.9.1209 · Cited by 165 · see citing works

Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study: Research Article: Escitalopram in Long-Term Treatment of SAD

Lader, M., Stender, K., Bürger, V., & Nil, R. (2004) · Depression and Anxiety · doi:10.1002/da.20014 · Cited by 163 · see citing works

Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine

Hollander, E., Allen, A., Steiner, M., Wheadon, D. E., Oakes, R., Burnham, D. B., & Paroxetine OCD Study Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0919 · Cited by 156 · see citing works

Comparative Risk for Harms of Second-Generation Antidepressants: A Systematic Review and Meta-Analysis

Gartlehner, G., Thieda, P., Hansen, R. A., Gaynes, B. N., DeVeaugh-Geiss, A., Krebs, E. E., & Lohr, K. N. (2008) · Drug Safety · doi:10.2165/00002018-200831100-00004 · Cited by 150 · see citing works

A Double-Blind, Placebo-Controlled Study of Fluoxetine in Depressed Patients With Alzheimer’s Disease

Petracca, G., Chemerinski, E., & STARKSTEIN, S. E. (2001) · International Psychogeriatrics · doi:10.1017/s104161020100761x · Cited by 150 · see citing works

Sertraline in the Treatment of Panic Disorder

Pollack, M. H., Otto, M. W., Worthington, J. J., Manfro, G. G., & Wolkow, R. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.1010 · Cited by 144 · see citing works

Sertraline in the treatment of panic disorder

Londborg, P. D., Wolkow, R., Smith, W. T., DuBoff, E., England, D., Ferguson, J. M., Rosenthal, M. H., & Weise, C. C. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.1.54 · Cited by 142 · see citing works

A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression

Tollefson, G. D., Bosomworth, J. C., Heiligenstein, J. H., Potvin, J. H., & Holman, S. (1995) · International Psychogeriatrics · doi:10.1017/s1041610295001888 · Cited by 142 · see citing works

Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design.

Geller, B., Cooper, T. B., Graham, D. L., Marsteller, F. A., & Bryant, D. M. (1989) · PubMed · Cited by 142 · see citing works

Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group.

Justice, A. C., Rabeneck, L., Hays, R. D., Wu, A. W., & Bozzette, S. A. (1999) · PubMed · Cited by 141 · see citing works

A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia

Hellerstein, D. J., Yanowitch, P., Rosenthal, J., Samstag, L. W., Maurer, M., Kasch, K. L., Burrows, L., Poster, M., Cantillon, M., & Winston, A. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1169 · Cited by 141 · see citing works

Escitalopram in the Treatment of Panic Disorder

Stahl, S. M., Gergel, I. P., & Li, D. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1107 · Cited by 139 · see citing works

Efficacy of Sertraline in a 12-Week Trial for Generalized Anxiety Disorder

Allgulander, C., Dahl, A. A., Austin, C., Morris, P., Søgaard, J., Fayyad, R. S., Kutcher, S., & Clary, C. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1642 · Cited by 139 · see citing works

Cortical correlates of false expectations during pain intensity judgments—a possible manifestation of placebo/nocebo cognitions

Lorenz, J., Hauck, M., Paur, R. C., Nakamura, Y., Zimmermann, R., Bromm, B., & Engel, A. K. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.03.010 · Cited by 137 · see citing works

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

Chouinard, G., Goodman, W. K., Greist, J. H., Jenike, M. A., Rasmussen, S., White, K., Hackett, E., Gaffney, M., & Bick, P. A. (1990) · PubMed · Cited by 136 · see citing works

Paroxetine Treatment in Children and Adolescents With Major Depressive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Emslie, G. J., Wagner, K. D., Kutcher, S., Krulewicz, S., Fong, R., CARPENTER, D. J., Lipschitz, A., Machin, A., & Wilkinson, C. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000214189.73240.63 · Cited by 136 · see citing works

Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

Stein, D. J., Andersen, E. W., Tonnoir, B., & Fineberg, N. A. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x178838 · Cited by 134 · see citing works

Fluoxetine in Depressed Patients on Dialysis

Blumenfield, M., Levy, N. B., Spinowitz, B., Charytan, C., Beasley, C. M., Dubey, A. K., Solomon, R., Todd, R., Goodman, A. I., & Bergstrom, R. F. (1997) · The International Journal of Psychiatry in Medicine · doi:10.2190/wq33-m54t-xn7l-v8mx · Cited by 133 · see citing works

Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial

Pohl, R. B., Wolkow, R., & Clary, C. M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1189 · Cited by 133 · see citing works

Physician Response to Patient Reports of Adverse Drug Effects

Golomb, B. A., McGraw, J. J., Evans, M. A., & Dimsdale, J. E. (2007) · Drug Safety · doi:10.2165/00002018-200730080-00003 · Cited by 131 · see citing works

Efficacy and Tolerability of Paroxetine for the Long-Term Treatment of Generalized Anxiety Disorder

Stocchi, F., Nordera, G., Jokinen, R., Lepola, U. M., Hewett, K., Bryson, H., Iyengar, M. K., & Paroxetine Generalized Anxiety Disorder Study Team (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0305 · Cited by 128 · see citing works

Escitalopram in the treatment of social anxiety disorder

Kasper, S. F., Stein, D. J., Loft, H., & Nil, R. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.3.222 · Cited by 126 · see citing works

Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results From an 8-Week Randomized, Placebo-Controlled Trial

Lenze, E. J., Mulsant, B. H., Shear, M. K., Dew, M. A., Miller, M. D., Pollock, B. G., Houck, P., Tracey, B., & Reynolds, C. F. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.146 · Cited by 122 · see citing works

Fixed-dose fluoxetine therapy for depression.

Jf, W., Dunlop, S. R., Dornseif, B. E., & Zerbe, R. L. (1987) · PubMed · Cited by 120 · see citing works

Treatment of obsessive—compulsive disorder with fluvoxamine

Goodman, W. K., Kozak, M., Liebowitz, M. R., & White, K. L. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199603000-00003 · Cited by 120 · see citing works

Response to Desipramine Treatment in Adolescent Depression: A Fixed-Dose, Placebo-Controlled Trial

Kutcher, S., Boulos, C., Ward, B., Marton, P., SIMEON, J. G., Ferguson, H. B., Szalai, J. P., KATIC, M., Roberts, N., Dubois, C., et al. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199406000-00010 · Cited by 118 · see citing works

Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trials

Goodman, W. K., Bose, A., & Wang, Q. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.11.011 · Cited by 117 · see citing works

A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Anxiety Disorder

Liebowitz, M. R., Stein, M. B., Tancer, M. E., Carpenter, D. J., Oakes, R., & Pitts, C. D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0113 · Cited by 117 · see citing works

Double-Blind Comparison of Sertraline and Placebo in Stroke Patients With Minor Depression and Less Severe Major Depression

Murray, V., von Arbin, M., Bartfai, A., Berggren, A.-L., Landtblom, A., Lundmark, J., Näsman, P., Olsson, J., Samu­elsson, M., Terént, A., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0606 · Cited by 115 · see citing works

Escitalopram in the Treatment of Depressed Elderly Patients

Kasper, S. F. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.10.884 · Cited by 115 · see citing works

Escitalopram and paroxetine in the treatment of generalised anxiety disorder: Randomised, placebo-controlled, double-blind study

Baldwin, D. S., Huusom, A. K. T., & Mæhlum, E. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.012799 · Cited by 114 · see citing works

Effect of Fluvoxamine on Panic Disorder

Hoehn‐Saric, R., McLeod, D. R., & Hipsley, P. A. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00004 · Cited by 112 · see citing works

A Randomized, Double-blind, Placebo-controlled Study of Citalopram in Adolescents With Major Depressive Disorder

von Knorring, A.-L., Olsson, G. I., Thomsen, P. H., Lemming, O. M., & Hultén, A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000219051.40632.d5 · Cited by 111 · see citing works

Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.

Fallon, B. A., Liebowitz, M. R., Campeas, R. B., Schneier, F. R., Marshall, R. D., Davies, S. O., Goetz, D. M., & Klein, D. F. (1998) · PubMed · doi:10.1001/archpsyc.55.10.918 · Cited by 111 · see citing works

Treatment of Major Depression in HIV-Seropositive Men

Zisook, S., Peterkin, J. J., Goggin, K. J., Sledge, P., Atkinson, J. H., & Grant, I. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0502 · Cited by 110 · see citing works

A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta‐analysis

Wilson, K., & Mottram, P. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1156 · Cited by 107 · see citing works

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

Paile‐Hyvärinen, M., Wahlbeck, K., & Eriksson, J. G. (2003) · BMC Family Practice · doi:10.1186/1471-2296-4-7 · Cited by 106 · see citing works

Placebo and Nocebo Responses, Cortisol, and Circulating Beta-Endorphin

Johansen, O., Brox, J. H., & Flaten, M. A. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000082626.56217.cf · Cited by 105 · see citing works

Effect of Treating Depression on Quality-of-Life and Exercise Tolerance in Severe COPD

Eiser, N. M., Harte, R., Karvounis, S., Phillips, C., & Isaac, M. T. (2005) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-57596 · Cited by 105 · see citing works

A Twelve-Week, Double-Blind, Randomized Comparison of Nortriptyline and Paroxetine in Older Depressed Inpatients and Outpatients

Mulsant, B. H., Pollock, B. G., Nebes, R. D., Miller, M. D., Sweet, R. A., Stack, J., Houck, P. R., Bensasi, S., Mazumdar, S., & Reynolds, C. F. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00009 · Cited by 104 · see citing works

Fluoxetine in Social Phobia: A Double-Blind, Placebo-Controlled Pilot Study

Kobak, K. A., Greist, J. H., Jefferson, J. W., & Katzelnick, D. J. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00005 · Cited by 103 · see citing works

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder

Hollander, E., Koran, L. M., Goodman, W. K., Greist, J. H., Ninan, P. T., Yang, H., Li, D., & Barbato, L. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0604 · Cited by 103 · see citing works

An International, Multicenter, Placebo-Controlled Trial of Paroxetine in Adolescents with Major Depressive Disorder

Berard, R. M. F., Fong, R., Carpenter, D. J., Thomason, C., & Wilkinson, C. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.59 · Cited by 102 · see citing works

Low-dose fluoxetine therapy for depression.

Wernicke, J. F., Dunlop, S. R., Dornseif, B. E., Bosomworth, J. C., & Humbert, M. (1988) · PubMed · Cited by 101 · see citing works

Efficacy and Tolerability of Controlled-Release and Immediate-Release Paroxetine in the Treatment of Depression

Golden, R. N., Nemeroff, C. B., McSorley, P., Pitts, C. D., & Dube, E. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0707 · Cited by 101 · see citing works

Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.

Modigh, K., Westberg, P., & Eriksson, E. (1992) · PubMed · Cited by 100 · see citing works

A Randomized Trial of Citalopram versus Placebo in Outpatients with Asthma and Major Depressive Disorder: A Proof of Concept Study

Brown, E. S., Vigil, L., Khan, D. A., Liggin, J. D. M., Carmody, T. J., & Rush, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.030 · Cited by 99 · see citing works

Escitalopram in the Treatment of Depressed Elderly Patients

Kasper, S. F., de Swart, H., & Andersen, H. F. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200510000-00008 · Cited by 99 · see citing works

Efficacy of Sertraline in Severe Generalized Social Anxiety Disorder

Liebowitz, M. R., DeMartinis, N. A., Weihs, K. L., Londborg, P. D., Smith, W. T., Chung, H., Fayyad, R. S., & Clary, C. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0708 · Cited by 96 · see citing works

Endogenous opiates and the placebo effect

Sauro, M. D., & Greenberg, R. P. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.07.001 · Cited by 95 · see citing works

Comparison of the tolerability and efficacy of citalopram and??amitriptyline in elderly depressed patients treated in general practice

Kyle, C. J., Petersen, H. E. H., & Over�, K. F. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)8:4 · Cited by 94 · see citing works

Superiority of Clomipramine over Imipramine in the

Modigh, K., Westberg, P., & Eriksson, E. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199208000-00007 · Cited by 92 · see citing works

Fluoxetine in posttraumatic stress disorder.

van der Kolk, B. A., Dreyfuss, D. A., Michaels, M. J., Shera, D., Berkowitz, R., Fisler, R. E., & Saxe, G. (1994) · PubMed · Cited by 92 · see citing works

Efficacy, Safety, and Tolerability of Sertraline in Patients with Late‐Life Depression and Comorbid Medical Illness

Sheikh, J. I., Cassidy‐Eagle, E. L., Doraiswamy, P. M., Salomon, R. M., Hornig, M., Holland, P. J., Mandel, F. S., Clary, C. M., & Burt, T. (2003) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52015.x · Cited by 91 · see citing works

Trimipramine in physical illness with depression.

Rifkin, A. E., Reardon, G. T., Siris, S. G., Karagji, B., Kim, Y. S., Hackstaff, L., & Endicott, N. A. (1985) · PubMed · Cited by 91 · see citing works

Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions.

Liccardi, G., Senna, G., Russo, M. L., Bonadonna, R. C., Crivellaro, M., Dama, A., D’Amato, M., D’Amato, G., Canonica, G. W., & Passalacqua, G. (2004) · PubMed · Cited by 88 · see citing works

Efficacy and Tolerability of Controlled-Release Paroxetine in the Treatment of Panic Disorder

Sheehan, D. V., Burnham, D. B., Iyengar, M. K., Perera, P., & Paxil CR Panic Disorder Study Group (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0105 · Cited by 85 · see citing works

Placebo-Controlled, Multicenter Study of Sertraline Treatment for Obsessive-Compulsive Disorder

Kronig, M. H., Apter, J. T., Asnis, G. M., Bystritsky, A., Curtis, G., Ferguson, J. M., Landbloom, R. P., Munjack, D. J., Riesenberg, R. A., Robinson, D. G., et al. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199904000-00013 · Cited by 84 · see citing works

A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression

D, M. F. M., Amsterdam, J. D., Deltito, J. A., Salzman, C., Schwaller, M., & Dünner, D. L. (1998) · Annals of Clinical Psychiatry · doi:10.1023/a:1022337927842 · Cited by 82 · see citing works

A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder

Moscovitch, A., Blashko, C. A., Eagles, J., DARCOURT, G., Thompson, C., Kasper, S. F., & Lane, R. M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1594-8 · Cited by 82 · see citing works

A placebo-controlled trial of paroxetine in the treatment of major depression.

Smith, W. T., & Glaudin, V. (1992) · PubMed · Cited by 80 · see citing works

Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial

Martényi, F., & Soldatenkova, V. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.10.007 · Cited by 79 · see citing works

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

Jenike, M. A., Baer, L., D, P. S. M., Weilburg, J. B., Holland, A. J., & Seymour, R. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1328 · Cited by 79 · see citing works

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

Asnis, G. M., Hameedi, F. A., Goddard, A. W., Potkin, S. G., Black, D. W., Jameel, M., Desagani, K., & Woods, S. W. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00265-7 · Cited by 76 · see citing works

A Double-Blind Placebo-Controlled Study of Controlled Release Fluvoxamine for the Treatment of Generalized Social Anxiety Disorder

Westenberg, H. G. M., Stein, D. J., Yang, H., Li, D., & Barbato, L. M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104906.75206.8b · Cited by 73 · see citing works

Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo [published erratum appears in Am J Psychiatry 1990 Oct;147(10):1393]

Jenike, M. A., Baer, L., D, P. S. M., Minichiello, W. E., Holland, A. J., & Seymour, R. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.7.923 · Cited by 73 · see citing works

Sertraline Treatment for Generalized Anxiety Disorder

Brawman‐Mintzer, O., Knapp, R. G., Rynn, M. A., Carter, R. E., & Rickels, K. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0603 · Cited by 72 · see citing works

Stroke, vascular risk factors and depression

Stewart, R. J., Prince, M. J., Richards, M., Brayne, C., & MANN, A. H. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.1.23 · Cited by 71 · see citing works

Fluvoxamine-Controlled Release Formulation for the Treatment of Generalized Social Anxiety Disorder

Davidson, J. R. T., Yaryura-Tobias, J. A., DuPont, R. L., Stallings, L., Barbato, L. M., van der Hoop, R. G., & Li, D. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000106222.36344.96 · Cited by 69 · see citing works

The Additive Impact of Anxiety and a Placebo on Pain

Staats, P. S., Staats, A. W., & Hekmat, H. M. (2001) · Pain Medicine · doi:10.1046/j.1526-4637.2001.01046.x · Cited by 69 · see citing works

Clomipramine Treatment of Agoraphobic Women

Johnston, D. G. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290073009 · Cited by 68 · see citing works

Controlled-Release Paroxetine in the Treatment of Patients With Social Anxiety Disorder

Lepola, U. M., Bergtholdt, B., Lambert, J. S., Davy, K., & Ruggiero, L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0213 · Cited by 66 · see citing works

Psychopharmacological treatment of social phobia.

Liebowitz, M. R., Gorman, J., Fyer, A. J., Campeas, R. B., Levin, A. P., Davies, S., & Df, K. (1985) · PubMed · Cited by 66 · see citing works

Controlled efficacy study of fluoxetine in dysthymia

Vanelle, J., Attar-Levy, D., Poirier, M. F., Bouhassira, M., Blin, P., & Olié, J. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.4.345 · Cited by 65 · see citing works

Notes for a Critical Personality Psychology: Making Room under the Critical Psychology Umbrella

Ouellette, S. C. (2007) · Social and Personality Psychology Compass · doi:10.1111/j.1751-9004.2007.00039.x · Cited by 63 · see citing works

A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression

Fava, M., Amsterdam, J. D., Deltito, J. A., et al. (1998) · Annals of Clinical Psychiatry · doi:10.3109/10401239809147030 · Cited by 63 · see citing works

Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: Randomised, placebo-controlled trial

Michelson, D., Allgulander, C., Dantendorfer, K., Knezevic, A., Maierhofer, D., Micev, V., Paunovic, V. R., Timotijevic, I., Sarkar, N., Skoglund, L., et al. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.6.514 · Cited by 62 · cited 1× · see citing works

A placebo‐controlled, double‐blind, clinical trial of paroxetine in depressed outpatients

Rickels, K., Amsterdam, J. D., Clary, C. M., Fox, I., Schweizer, E. E., & Weise, C. C. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07188.x · Cited by 59 · see citing works

Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.

Dunlop, S. R., Dornseif, B. E., Wernicke, J., & Potvin, J. H. (1990) · PubMed · Cited by 59 · see citing works

Effectiveness of Low Doses of Paroxetine Controlled Release in the Treatment of Major Depressive Disorder

Trivedi, M. H., Pigott, T. A., Perera, P., Dillingham, K., Carfagno, M. L., & Pitts, C. D. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1010 · Cited by 58 · see citing works

Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.

Greist, J. H., Jefferson, J. W., Rosenfeld, R., Gutzmann, L. D., March, J. S., & Barklage, N. E. (1990) · PubMed · Cited by 58 · see citing works

Double-blind placebo-controlled pilot study of paroxetine for specific phobia

Benjamin, J., Ben-Zion, I. Z., Karbofsky, E., & Dannon, P. N. (2000) · Psychopharmacology · doi:10.1007/s002130000372 · Cited by 56 · see citing works

The Effects of Manipulating Expectations Through Placebo and Nocebo Administration on Gastric Tachyarrhythmia and Motion-Induced Nausea

Levine, M. E., Stern, R. M., & Koch, K. L. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221377.52036.50 · Cited by 53 · see citing works

Antidepressant prescription for depression in general practice in The Netherlands.

van Marwijk, H., Bijl, D., r, H. J. A., & de Haan, M. (2001) · Pharmacy World & Science · doi:10.1023/a:1011294305606 · Cited by 51 · see citing works

Can Physiologic Assessment and Side Effects Tease Out Differences in PTSD Trials? A Double-Blind Comparison of Citalopram, Sertraline, and Placebo

Tucker, P. M., MD, Potter-Kimball, R., RN, MS, Wyatt, D. B., Masters, B., Parker, D. E., PhD, Burgin, C. E., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4179 · Cited by 49 · see citing works

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial

Stein, D. J., Westenberg, H. G. M., Yang, H., Li, D., & Barbato, L. M. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570300364x · Cited by 48 · see citing works

Treatment of Dysthymia With Sertraline

Ravindran, A. V., Guelfi, J. D., Lane, R. M., & Cassano, G. B. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1103 · Cited by 47 · see citing works

The Oral Dose-Effect Relationship for Fluvoxamine: a Fixed-Dose Comparison Against Placebo in Depressed Outpatients

Walczak, D. D., Apter, J. T., Halikas, J. A., Borison, R. L., Carman, J. S., Post, G., PATRICK, R. O., Cohn, J. N., Cunningham, L. A., Rittberg, B. R., et al. (1996) · Annals of Clinical Psychiatry · doi:10.3109/10401239609147751 · Cited by 47 · see citing works

Paroxetine versus placebo: a double-blind comparison in depressed patients.

Claghorn, J. L., Kiev, A., Rickels, K., Smith, W. T., & Dunbar, G. C. (1992) · PubMed · Cited by 45 · see citing works

A double-blind, placebo-controlled dose-finding study with sertraline.

Amin, M., Lehmann, H., & Mirmiran, J. (1989) · PubMed · Cited by 42 · see citing works

Short- and Long-Term Treatment of Obsessive-Compulsive Disorder with Fluvoxamine

Mallya, G. K., White, K., WATERNAUX, C. M., & Quay, S. (1992) · Annals of Clinical Psychiatry · doi:10.3109/10401239209150443 · Cited by 41 · see citing works

The Power of Expectation – Understanding the Placebo and Nocebo Phenomenon

Rief, W., Hofmann, S. G., & Nestoriuc, Y. (2008) · Social and Personality Psychology Compass · doi:10.1111/j.1751-9004.2008.00121.x · Cited by 40 · see citing works

Fluoxetine versus other types of pharmacotherapy for depression (Review)

Cipriani, A., Brambilla, P., Furukawa, T. A., Geddes, J. R., Gregis, M., Hotopf, M. H., Malvini, L., & Barbui, C. (2005) · Cited by 39 · see citing works

A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia

Heiligenstein, J. H., Tollefson, G. D., & Faries, D. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00007 · Cited by 38 · see citing works

Assessment of Adverse Events Associated With Triptans—Methods of Assessment Influence the Results

Sheftell, F. D., Feleppa, M., Tepper, S. J., Rapoport, A. M., Ciannella, L., & BIGAL, M. E. (2004) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2004.04191.x · Cited by 38 · see citing works

Alcohol abuse: a source of reversible functional disability among residents of a VA nursing home

Oslin, D. W., Streim, J. E., Parmelee, P. A., Boyce, A. A., & Katz, I. R. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199708)12:8 · Cited by 36 · see citing works

A double-blind, placebo-controlled study of paroxetine in depressed outpatients.

Kiev, A. (1992) · PubMed · Cited by 36 · see citing works

Paroxetine in the treatment of obsessive‐compulsive disorder: randomized, double‐blind, placebo‐controlled study in Japanese patients

Kamijima, K., Murasaki, M., Asai, M., Higuchi, T., Nakajima, T., Taga, C., & Matsunaga, H. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01278.x · Cited by 35 · see citing works

Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: A pilot study

Schwartz, J. A. J., & McDaniel, J. S. (1999) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1999)9:2 · Cited by 35 · see citing works

The effect of low dose lofepramine in depressed elderly patients in general medical wards.

Tan, R., Barlow, R., Abel, C., Reddy, S., Palmer, A. J., Fletcher, A., Nicholl, C., Bm, P., & Bulpitt, C. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04284.x · Cited by 33 · see citing works

The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies

Sheikh, J. I., Londborg, P. D., Clary, C. M., & Fayyad, R. S. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015060-00004 · Cited by 33 · see citing works

A double blind comparison of lofepramine, imipramine and placebo in patients with primary depression

Feighner, J. P., Meridith, C. H., and, J. E. D., & HENDRICKSON, G. G. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00918.x · Cited by 26 · see citing works

Placebo/Nocebo Symptom Reporting in a Sham Herbal Supplement Trial

Link, J., Haggard, R., Kelly, K. S., & Forrer, D. (2006) · Evaluation & the Health Professions · doi:10.1177/0163278706293403 · Cited by 24 · see citing works

Sex-related differences in nortriptyline-induced side-effects among depressed patients

Pomara, N., Shao, B., Choi, S. J., Tun, H., & Suckow, R. F. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00175-0 · Cited by 21 · see citing works

Placebo‐Controlled trial of paroxetine in depressive illness

Edwards, J. G., & Goldie, A. (1993) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470080306 · Cited by 14 · see citing works

Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials

Brinkhaus, B., Pach, D., Lüdtke, R., & Willich, S. N. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.06.005 · Cited by 14 · see citing works

Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.

Ferguson, J. M., MENDELS, J., & Manowitz, N. R. (1994) · PubMed · Cited by 10 · see citing works

Do hypnotic analgesic interventions contain placebo effects?

Price, D. (2006) · Pain · doi:10.1016/j.pain.2006.04.021 · Cited by 10 · see citing works

Placebo-Associated Blood Pressure Response and Adverse Effects in the Treatment of Hypertension

Preston, R. A., Materson, B. J., Reda, D. J., & Williams, D. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1449 · Cited by 2 · see citing works

Untitled work

Emslie (1998) · doi:10.1002/(sici)1520-6394(1998)7:1

The placebo response in medicine: minimize, maximize or personalize?

Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671 · see citing works

Placebo and the New Physiology of the Doctor-Patient Relationship

Benedetti, F. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2012 · Cited by 492 · see citing works

Effects of empathic and positive communication in healthcare consultations: a systematic review and meta-analysis

Howick, J., Moscrop, A., Mebius, A., Fanshawe, T. R., Lewith, G. T., Bishop, F. L., Mistiaen, P., Roberts, N. W., Dieninytė, E., Hu, X.-Y. M., et al. (2018) · Journal of the Royal Society of Medicine · doi:10.1177/0141076818769477 · Cited by 472 · see citing works

The Nocebo Effect and Its Relevance for Clinical Practice

Colloca, L., & Miller, F. G. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182294a50 · Cited by 431 · see citing works

Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice

Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323 · see citing works

Psychobiological mechanisms of placebo and nocebo effects: pathways to improve treatments and reduce side effects

Petrie, K. J., & Rief, W. (2019) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-102907 · Cited by 309 · see citing works

Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review

Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299 · see citing works

Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview

Golder, S., Loke, Y. K., & Bland, M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001026 · Cited by 270 · see citing works

To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent

Wells, R. E., & Kaptchuk, T. J. (2012) · The American Journal of Bioethics · doi:10.1080/15265161.2011.652798 · Cited by 270 · see citing works

How to Use the New DSM-5 Somatic Symptom Disorder Diagnosis in Research and Practice: A Critical Evaluation and a Proposal for Modifications

Rief, W., & Martin, A. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153745 · Cited by 251 · see citing works

Side effects of antidepressants during long-term use in a naturalistic setting

Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., & Hoogendijk, W. J. G. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.001 · Cited by 239 · see citing works

Nocebo Phenomena in Medicine

Häuser, W., Hansen, E., & Enck, P. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0459 · Cited by 230 · see citing works

The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management

Montejo, A. L., Montejo, L., & Baldwin, D. S. (2018) · World Psychiatry · doi:10.1002/wps.20509 · Cited by 191 · see citing works

Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects

Benedetti, F., Carlino, E., & Piedimonte, A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00066-1 · Cited by 184 · see citing works

A Systematic Review on the Acceptability and Tolerability of Transcranial Direct Current Stimulation Treatment in Neuropsychiatry Trials

Aparicio, L. V. M., Guarienti, F. A., Razza, L. B., Carvalho, A. F., Fregni, F., & Brunoni, A. R. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.05.004 · Cited by 178 · see citing works

Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: A review of current practice

Jonsson, U., Alaie, I., Parling, T., & Arnberg, F. K. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.02.005 · Cited by 175 · see citing works

The nocebo effect of drugs

Planès, S., Villier, C., & Mallaret, M. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.208 · Cited by 173 · see citing works

Assessing general side effects in clinical trials: reference data from the general population

Rief, W., BARSKY, A. J., Glombiewski, J. A., Nestoriuc, Y., Glaesmer, H., & Brähler, E. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2067 · Cited by 166 · see citing works

Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: A randomized, double-blind, placebo-controlled, pilot clinical trial

Talaeı, A., Moghadam, M. H., Tabassi, S. A. S., & Mohajeri, S. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.035 · Cited by 166 · see citing works

Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials

Haas, J. W., Bender, F. L., Ballou, S., Kelley, J. M., Wilhelm, M., Miller, F. G., Rief, W., & Kaptchuk, T. J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.43955 · Cited by 156 · see citing works

Tripping on nothing: placebo psychedelics and contextual factors

Olson, J. A., Suissa-Rocheleau, L., Lifshitz, M., Raz, A., & Veissière, S. P. L. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05464-5 · Cited by 143 · see citing works

Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials

Rief, W., Bingel, U., Schedlowski, M., & Enck, P. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.204 · Cited by 133 · see citing works

The placebo response: how words and rituals change the patient's brain

Benedetti, F., & Amanzio, M. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.04.034 · Cited by 132 · see citing works

Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder, and functional somatic syndromes: European Network on Somatic Symptom Disorders recommendations

Rief, W., Burton, C., Frostholm, L., Henningsen, P., Kleinstäuber, M., Kop, W. J., Löwe, B., Martin, A., Malt, U., Rosmalen, J., et al. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000502 · Cited by 129 · see citing works

Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: A literature review

Cafarella, P., Effing, T., Usmani, Z. A., & Frith, P. A. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02148.x · Cited by 128 · see citing works

Utilizing placebo mechanisms for dose reduction in pharmacotherapy

Doering, B. K., & Rief, W. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.12.001 · Cited by 125 · see citing works

Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines

Nestoriuc, Y., Orav, E. J., Liang, M. H., Horne, R., & BARSKY, A. J. (2010) · Arthritis Care & Research · doi:10.1002/acr.20160 · Cited by 116 · see citing works

Placebo 2.0: the impact of expectations on analgesic treatment outcome

Bingel, U. (2020) · Pain · doi:10.1097/j.pain.0000000000001981 · Cited by 113 · see citing works

The Clinical Implications of Nocebo Effects for Biosimilar Therapy

Colloca, L., Panaccione, R., & Murphy, T. K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01372 · Cited by 108 · see citing works

Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach

Montejo, A. L., Prieto, N., de Alarcón, R., Casado‐Espada, N. M., de la Iglesia, J., & Montejo, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101640 · Cited by 109 · see citing works

Lessons learned from placebo groups in antidepressant trials

Mora, M. C. S., Nestoriuc, Y., & Rief, W. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0394 · Cited by 105 · see citing works

Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study

Nestoriuc, Y., von Blanckenburg, P., Schuricht, F., Barsky, A. J., Hadji, P., Albert, U.-S., & Rief, W. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw266 · Cited by 103 · see citing works

Can expectations produce symptoms from infrasound associated with wind turbines?

Crichton, F., Dodd, G., Schmid, G., Gamble, G. D., & Petrie, K. J. (2013) · Health Psychology · doi:10.1037/a0031760 · Cited by 99 · see citing works

Placebo and Nocebo Effects: A Complex Interplay Between Psychological Factors and Neurochemical Networks

Frisaldi, E., Piedimonte, A., & Benedetti, F. (2015) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2014.976785 · Cited by 88 · see citing works

How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions

Manaï, M., van Middendorp, H., Veldhuijzen, D. S., Huizinga, T. W. J., & Evers, A. W. M. (2019) · PAIN Reports · doi:10.1097/pr9.0000000000000699 · Cited by 84 · see citing works

The Nocebo Effect

Colloca, L. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022723-112425 · Cited by 90 · see citing works

Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review

Amanzio, M., Mitsikostas, D. D., Giovannelli, F., Bartoli, M., Cipriani, G. E., & Brown, W. A. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100253 · Cited by 81 · see citing works

Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials

Howick, J., Webster, R., Kirby, N., & Hood, K. (2018) · Trials · doi:10.1186/s13063-018-3042-4 · Cited by 77 · see citing works

Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports

Maund, E., Guski, L. S., & Gøtzsche, P. C. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.151104 · Cited by 74 · see citing works

Differences in serotonin receptor expression in the brainstem may explain the differential ability of a serotonin agonist to block seizure-induced sudden death in DBA/2 vs. DBA/1 mice

Faingold, C. L., Randall, M., Mhaskar, Y., & Uteshev, V. V. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.043 · Cited by 72 · see citing works

Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain

Wiffen, P. J., Derry, S., & Moore, R. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011056.pub2 · Cited by 71 · see citing works

Die Rolle von Placebo- und Nocebomechanismen bei depressiven Erkrankungen und ihrer Therapie

Rief, W. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00940-x · Cited by 70 · see citing works

Rethinking psychopharmacotherapy: the role of treatment context and brain plasticity in antidepressant and antipsychotic interventions.

Rief, W., Barsky, A. J., Bingel, U., Doering, B. K., Schwarting, R., Wöhr, M., & Schweiger, U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.008 · Cited by 67 · see citing works

Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review

Smith, S. M., Chang, D. R., Pereira, A. C., Shah, N., Gilron, I., Katz, N. P., Lin, A. H., McDermott, M., Rappaport, B. A., Rowbotham, M. C., et al. (2012) · Pain · doi:10.1016/j.pain.2012.08.009 · Cited by 65 · see citing works

The placebo-nocebo response: controversies and challenges from clinical and research perspective

Jakovljevic, M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.014 · Cited by 63 · see citing works

Impact of Antidepressant Drugs on Sexual Function and Satisfaction

Baldwin, D. S., Manson, C., & Nowak, M. (2015) · CNS Drugs · doi:10.1007/s40263-015-0294-3 · Cited by 60 · see citing works

Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease

Pollok, J., van Agteren, J. E., & Carson-Chahhoud, K. V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012346.pub2 · Cited by 59 · see citing works

Unhelpful information about adverse drug reactions

Tan, K., Petrie, K. J., Faasse, K., Bolland, M. J., & Grey, A. B. (2014) · BMJ · doi:10.1136/bmj.g5019 · Cited by 60 · see citing works

Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations

Smith, S. M., Wang, A. T., Katz, N. P., McDermott, M. P., Burke, L. B., Coplan, P., Gilron, I., Hertz, S. H., Lin, A. H., Rappaport, B. A., et al. (2013) · Pain · doi:10.1016/j.pain.2013.03.003 · Cited by 58 · see citing works

Placebos and the Placebo Effect in Drug Trials

Enck, P., & Klosterhalfen, S. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_269 · Cited by 58 · see citing works

Are placebo and drug-specific effects additive? Questioning basic assumptions of double-blinded randomized clinical trials and presenting novel study designs

Κube, T., & Rief, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.022 · Cited by 57 · see citing works

The psychedelic afterglow phenomenon: A systematic review of subacute effects of classic serotonergic psychedelics

Evens, R., Schmidt, M. E., Majić, T., & Schmidt, T. T. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231172254 · Cited by 56 · see citing works

The nocebo effect: A clinicians guide

Data-Franco, J., & Berk, M. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412464717 · Cited by 56 · see citing works

Prevalence and risk factors of excessive daytime sleepiness in major depression: A study with 703 individuals referred for polysomnography

Hein, M., Lanquart, J., Loas, G., Hubain, P., & Linkowski, P. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.016 · Cited by 58 · see citing works

Placebo-Induced Improvements: How Therapeutic Rituals Affect the Patient’s Brain

Benedetti, F. (2012) · Innovations in Acupuncture and Medicine · doi:10.1016/j.jams.2012.03.001 · Cited by 59 · see citing works

Constipation and risk of Parkinson’s disease: A Danish population-based cohort study

Svensson, E., Henderson, V. W., Borghammer, P., Horváth–Puhó, E., & Sørensen, H. T. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.016 · Cited by 57 · see citing works

The current clinical knowledge on the treatment of gambling disorder: A summary

Hloch, K., Mladěnka, P., Doseděl, M., Adriani, W., & Zoratto, F. (2017) · Synapse · doi:10.1002/syn.21976 · Cited by 54 · see citing works

A systematic review of factors associated with side‐effect expectations from medical interventions

Smith, L., Webster, R., & Rubin, G. J. (2020) · Health Expectations · doi:10.1111/hex.13059 · Cited by 54 · see citing works

Beliefs about medication predict the misattribution of a common symptom as a medication side effect — Evidence from an analogue online study

Heller, M. K., Chapman, S., & Horne, R. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.10.003 · Cited by 52 · see citing works

Mechanisms and Clinical Implications of the Placebo Effect: Is There a Potential for the Elderly? A Mini-Review

Bingel, U., Colloca, L., & Vase, L. (2010) · Gerontology · doi:10.1159/000322090 · Cited by 48 · see citing works

Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis

Meister, R., Abbas, M., Antel, J., Peters, T., Pan, Y., Bingel, U., Nestoriuc, Y., & Hebebrand, J. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1244-7 · Cited by 51 · see citing works

Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I)

Smith, S. G., Sestak, I., Howell, A., Forbes, J., & Cuzick, J. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.7439 · Cited by 51 · see citing works

The Link between Health Complaints and Wind Turbines: Support for the Nocebo Expectations Hypothesis

Crichton, F., Chapman, S., Cundy, T., & Petrie, K. J. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00220 · Cited by 50 · see citing works

Learning to experience side effects after antidepressant intake – Results from a randomized, controlled, double-blind study

Rheker, J., Winkler, A., Doering, B. K., & Rief, W. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4466-8 · Cited by 52 · see citing works

A Review of Ocular Complications Associated with Medications Used for Anxiety, Depression, and Stress

Constable, P. A., Al-Dasooqi, D., Bruce, R., & Senthil, M. P. (2022) · Clinical Optometry · doi:10.2147/opto.s355091 · Cited by 48 · see citing works

Placebo and nocebo responses in drug trials of epilepsy

Zaccara, G., Giovannelli, F., & Schmidt, D. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.12.004 · Cited by 47 · see citing works

Efficacy of selective serotonin reuptake inhibitors and adverse events: Meta-regression and mediation analysis of placebo-controlled trials

Barth, M., Kriston, L., Klostermann, S., Barbui, C., Cipriani, A., & Linde, K. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.150136 · Cited by 46 · see citing works

Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder

Meister, R., von Wolff, A., Mohr, H., Nestoriuc, Y., Härter, M. C., Hölzel, L. P., & Kriston, L. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.10.007 · Cited by 44 · see citing works

Rate and predictors of negative effects of psychotherapy in psychiatric and psychosomatic inpatients

Rheker, J., Beisel, S., Kräling, S., & Rief, W. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.04.042 · Cited by 44 · see citing works

How placebo characteristics can influence estimates of intervention effects in trials

Howick, J., & Hoffmann, T. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.171400 · Cited by 44 · see citing works

Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach

Montejo, A. L., de Alarcón, R., Prieto, N., Acosta, J. M., Buch-Vicente, B., & Montejo, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020308 · Cited by 43 · see citing works

Reporting of adverse events in cognitive behavioural therapy for insomnia: A systematic examination of randomised controlled trials

Condon, H. E., Maurer, L. F., & Kyle, S. D. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101412 · Cited by 42 · see citing works

Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis

Meister, R., Jansen, A., Härter, M. C., Nestoriuc, Y., & Kriston, L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.024 · Cited by 41 · see citing works

Late-life depression: issues for the general practitioner

Damme, A. V., Declercq, T., Lemey, L., Tandt, H. L. N., & Petrović, M. (2018) · International Journal of General Medicine · doi:10.2147/ijgm.s154876 · Cited by 43 · see citing works

Is somatosensory amplification a risk factor for an increased report of side effects? Reference data from the German general population

Doering, B. K., Nestoriuc, Y., BARSKY, A. J., Glaesmer, H., Brähler, E., & Rief, W. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.10.010 · Cited by 39 · see citing works

Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ma, C., Panaccione, N., Nguyen, T. M., Guizzetti, L., Parker, C. E., Hussein, I. M., Casteele, N. V., Khanna, R., Dulai, P. S., Singh, S., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz087 · Cited by 38 · see citing works

Nocebo Effects in Concussion

Polich, G. R., Iaccarino, M. A., Kaptchuk, T. J., Morales-Quezada, L., & ZAFONTE, R. D. (2019) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001290 · Cited by 38 · see citing works

Nocebo Effects: Neurobiological Mechanisms and Strategies for Prevention and Optimizing Treatment

Kleine‐Borgmann, J., & Bingel, U. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.02.005 · Cited by 36 · see citing works

Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.

Matsuoka, H., Makimura, C., Koyama, A., Otsuka, M., Okamoto, W., Fujisaka, Y., Kaneda, H., Tsurutani, J., & Nakagawa, K. (2012) · PubMed · Cited by 34 · see citing works

The effect of symptom‐tracking apps on symptom reporting

MacKrill, K., Groom, K. M., & Petrie, K. J. (2020) · British Journal of Health Psychology · doi:10.1111/bjhp.12459 · Cited by 33 · see citing works

Incidence of Placebo Adverse Events in Randomized Clinical Trials of Targeted and Immunotherapy Cancer Drugs in the Adjuvant Setting

Chacon, M. R., Enrico, D. H., Burton, J., Waisberg, F., & Videla, V. M. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.5617 · Cited by 32 · see citing works

Informing About the Nocebo Effect Affects Patients’ Need for Information About Antidepressants—An Experimental Online Study

Nestoriuc, Y., Pan, Y., Kinitz, T., Weik, E., & Mora, M. C. S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.587122 · Cited by 31 · see citing works

"This may hurt": predictions in procedural disclosure may do harm

Krauss, B. S. (2015) · BMJ · doi:10.1136/bmj.h649 · Cited by 32 · see citing works

Informed Consent and Placebo Effects: A Content Analysis of Information Leaflets to Identify What Clinical Trial Participants Are Told about Placebos

Bishop, F. L., Adams, A. E. M., Kaptchuk, T. J., & Lewith, G. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039661 · Cited by 32 · see citing works

Nocebo Effect in Randomized Clinical Trials of Antidepressants in Children and Adolescents: Systematic Review and Meta-Analysis

Rojas-Mirquez, J. C., Rodríguez-Zúñiga, M. J. M., Bonilla-Escobar, F. J., García‐Perdomo, H. A., Petkov, M. P., Becerra, L. R., Borsook, D., & Linnman, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00375 · Cited by 30 · see citing works

Placebo mechanisms in depression: An experimental investigation of the impact of expectations on sadness in female participants

Anna, G. J., Rheker, J., Julia, W., Lea, R., & Rief, W. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.070 · Cited by 28 · see citing works

Benefit–Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis

Qizilbash, N., Méndez, I., & la Rosa, R. S.-D. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.006 · Cited by 28 · see citing works

A systematic review of adverse events in the placebo arm of donepezil trials: the role of cognitive impairment

Amanzio, M., Benedetti, F., & Vase, L. (2012) · International Psychogeriatrics · doi:10.1017/s1041610211002420 · Cited by 28 · see citing works

Reduced Treatment-Emergent Sexual Dysfunction as a Potential Target in the Development of New Antidepressants

Baldwin, D. S., Palazzo, C., & Masdrakis, V. G. (2013) · Depression Research and Treatment · doi:10.1155/2013/256841 · Cited by 26 · see citing works

The nocebo effect as a source of bias in the assessment of treatment effects

Wartolowska, K. A. (2019) · F1000Research · doi:10.12688/f1000research.17611.2 · Cited by 25 · see citing works

Noceboeffekte und Negativsuggestionen in der Anästhesie

Zech, N., Seemann, M., & Hansen, E. (2014) · Der Anaesthesist · doi:10.1007/s00101-014-2386-8 · Cited by 25 · see citing works

Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies

Madigan, D., Sigelman, D. W., Mayer, J. W., Furberg, C. D., & Avorn, J. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.05.002 · Cited by 25 · see citing works

A Positive Mood Induction for Reducing the Formation of Nocebo Effects from Side Effect Information

Geers, A. L., Close, S., Caplandies, F. C., & Vase, L. (2019) · Annals of Behavioral Medicine · doi:10.1093/abm/kaz005 · Cited by 23 · see citing works

Justice for Placebo: Placebo Effect in Clinical Trials and Everyday Practice

Knežević, N. N., Sič, A., Worobey, S. J., & Knezevic, E. (2025) · Medicines · doi:10.3390/medicines12010005 · Cited by 24 · see citing works

Working with patients’ treatment expectations – what we can learn from homeopathy

Wilhelm, M., Hermann, C., Rief, W., Schedlowski, M., Bingel, U., & Winkler, A. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1398865 · Cited by 22 · see citing works

Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial

He, Y.-Q., Zheng, Y., Xu, C., Yang, H., Wang, Z., Zhou, L., Yu, W. C., Zheng, D., & Zhu, J. (2014) · The Clinical Respiratory Journal · doi:10.1111/crj.12219 · Cited by 22 · see citing works

Effects of Patients’ Expectation in Dermatology: Evidence from Experimental and Clinical Placebo Studies and Implications for Dermatologic Practice and Research

Sondermann, W., Jockenhöfer, F., Dissemond, J., Pfaar, O., Bingel, U., & Schedlowski, M. (2021) · Dermatology · doi:10.1159/000513445 · Cited by 22 · see citing works

Assessment of adverse events in clinical drug trials: Identifying amitriptyline’s placebo- and baseline-controlled side effects.

Rheker, J., Rief, W., Doering, B. K., & Winkler, A. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000194 · Cited by 20 · see citing works

Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials

Palermo, S., Giovannelli, F., Bartoli, M., & Amanzio, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00502 · Cited by 20 · see citing works

Selective Serotonin Reuptake Inhibitors and Endothelial Function in Women

Hantsoo, L. V., Czarkowski, K. A., Child, J., Howes, C., & Epperson, C. N. (2014) · Journal of Women s Health · doi:10.1089/jwh.2013.4623 · Cited by 20 · see citing works

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

Trindade, E. M., Menon, D., Topfer, L.-A., & Coloma, C. (1998) · Europe PMC (PubMed Central) · Cited by 250 · see citing works

The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect.

Cheung, C. P., Thiyagarajah, M., Abraha, H. Y., Liu, C. S., Lanctôt, K., Kiss, A., Saleem, M., Juda, A., Levitt, A., Schaffer, A., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.004 · Cited by 5 · see citing works

Are Randomized Control Trial Outcomes Influenced by the Inclusion of a Placebo Group?

Rochon, P. A., Binns, M. A., Litner, J. A., Litner, G. M., Fischbach, M., Eisenberg, D. M., Kaptchuk, T. J., Stason, W. B., & Chalmers, T. C. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00149-8 · Cited by 34 · see citing works

Is the efficacy of selective serotonin reuptake inhibitors influenced by adverse events? Meta-regression and mediation analysis of placebo-controlled trials

Barth, M., Kriston, L., Klostermann, S., Barbui, C., Cipriani, A., & Linde, K. (2014) · German Medical Science (German Research Foundation) · doi:10.3205/14gmds202

Medication-Attributed Adverse Effects in Placebo Groups: Implications for Assessment of Adverse Effects

Rief, W., Avorn, J., & Barsky, A. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.2.155 · Cited by 167 · see citing works